NJ State Employees Deferred Compensation Plan’s Organon & Co OGN Stock Holding History

NJ State Employees Deferred Compensation Plan’s Portfolio OGN Stock Details OGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-8,025	Closed	-$224K	–	497
2022 Q4	$224K	Buy	+8,025	New	+$205K	0.04%	405
2022 Q3	–	Sell	-8,025	Closed	-$271K	–	482
2022 Q2	$271K	Hold	8,025	–	–	0.04%	380
2022 Q1	$280K	Hold	8,025	–	–	0.04%	408
2021 Q4	$244K	Hold	8,025	–	–	0.03%	444
2021 Q3	$263K	Hold	8,025	–	–	0.04%	425
2021 Q2	$243K	Buy	+8,025	New	+$264K	0.03%	459

Other funds holding OGN

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Mawer Investment Management Calgary, Alberta, Canada $14.7B AUM 12.5% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Lord, Abbett & Co Jersey City, New Jersey $34.9B AUM 72.7% 1-Year Est. Return

Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

NJ State Employees Deferred Compensation Plan's OGN Position: Q1 2023 in Review

NJ State Employees Deferred Compensation Plan sold out of Organon & Co (OGN) in Q1 2023, closing a stake of 8,025 shares — an estimated $224K sold.

NJ State Employees Deferred Compensation Plan first reported a position in OGN in Q2 2021 and held it in 6 quarters. The position peaked at $280K in Q1 2022. 767 funds tracked by Wall St. Rank hold OGN as of Q1 2023.

NJ State Employees Deferred Compensation Plan reported no remaining Organon & Co position as of Q1 2023 after selling out during the quarter.
NJ State Employees Deferred Compensation Plan sold 8,025 Organon & Co shares in Q1 2023, an estimated $224K.
NJ State Employees Deferred Compensation Plan first reported a position in Organon & Co in Q2 2021 and held it in 6 quarters.
NJ State Employees Deferred Compensation Plan's Organon & Co position peaked at $280K in Q1 2022.
767 funds tracked by Wall St. Rank held Organon & Co as of Q1 2023.

Based on NJ State Employees Deferred Compensation Plan's 13F filing for Q1 2023, filed 26 Apr 2023.